SCHEMBL21239424

SCHEMBL21239424

C/C=N\c1ccc(C)cc1NC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ GAA P10253 5/20 0.35
▸ RAPGEF4 Q8WZA2 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ HPGD P15428 2/20 0.32
▸ POLB P06746 2/20 0.32
▸ ALOX15 P16050 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ THRB P10828 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ MPI P34949 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8342155 0.79 GAA (0.37) CYP3A4ADRA2AKDM4EMAPTLMNA
SCHEMBL21131297 0.77 CYP3A4 (0.62) CYP3A4ADRA2AKDM4EMAPTLMNA
SCHEMBL8292092 0.77 CYP3A4 (0.62) CYP3A4ADRA2AKDM4EMAPTLMNA
SCHEMBL15981344 0.75 KDM4E (0.40) KDM4EMAPTALDH1A1HPGDPOLB
SCHEMBL10284425 0.75 GAA (0.41) CYP3A4ADRA2ALMNAHTTGAA
SCHEMBL22080559 0.75 KDM4E (0.40) KDM4EMAPTALDH1A1HPGDPOLB
SCHEMBL22791425 0.75 GAA (0.37) CYP3A4ADRA2AKDM4EMAPTHTT
SCHEMBL12305572 0.73 NPC1 (0.47) CYP3A4ADRA2AKDM4EMAPTLMNA
SCHEMBL16130442 0.73 CYP3A4 (0.40) CYP3A4ADRA2AKDM4EMAPTLMNA
SCHEMBL12830975 0.73 CYP3A4 (0.40) CYP3A4ADRA2AKDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3521286-B1 FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1 CANCER RESEARCH TECH LTD (GB) 2021-09-29 — — EP disclosed
EP-3521286-A1 FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1 Cancer Research Technology Ltd. (GB) 2019-08-07 — — EP disclosed
Send feedback